| Expression profiling identifies microRNA signature in pancreatic cancer EJ Lee, Y Gusev, J Jiang, GJ Nuovo, MR Lerner, WL Frankel, DL Morgan, ... International journal of cancer 120 (5), 1046-1054, 2007 | 1234 | 2007 |
| A community effort to assess and improve drug sensitivity prediction algorithms JC Costello, et all Nature Biotechnology, 2014 | 818 | 2014 |
| Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival J Jiang, Y Gusev, I Aderca, TA Mettler, DM Nagorney, DJ Brackett, ... Clinical cancer research 14 (2), 419-427, 2008 | 723 | 2008 |
| Real-time expression profiling of microRNA precursors in human cancer cell lines J Jiang, EJ Lee, Y Gusev, TD Schmittgen Nucleic acids research 33 (17), 5394-5403, 2005 | 686 | 2005 |
| Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors EJ Lee, M Baek, Y Gusev, DJ Brackett, GJ Nuovo, TD Schmittgen Rna 14 (1), 35-42, 2008 | 523 | 2008 |
| Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 234 | 2022 |
| miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor JK Park, JC Henry, J Jiang, C Esau, Y Gusev, MR Lerner, RG Postier, ... Biochemical and biophysical research communications 406 (4), 518-523, 2011 | 232 | 2011 |
| The REMBRANDT study, a large collection of genomic data from brain cancer patients Y Gusev, K Bhuvaneshwar, L Song, JC Zenklusen, H Fine, S Madhavan Nature Scientific Data 5, 2018 | 179 | 2018 |
| Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer JA Sosa, M Diener-West, Y Gusev, MA Choti, JR Lange, WC Dooley, ... Annals of surgical oncology 5 (2), 140-149, 1998 | 148 | 1998 |
| Rolling circle amplification: a new approach to increase sensitivity for immunohistochemistry and flow cytometry Y Gusev, J Sparkowski, A Raghunathan, H Ferguson Jr, J Montano, ... The American journal of pathology 159 (1), 63-69, 2001 | 127 | 2001 |
| Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation OA Elgamal, JK Park, Y Gusev, ACP Azevedo-Pouly, J Jiang, A Roopra, ... PloS one 8 (10), e76402, 2013 | 121 | 2013 |
| The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling B Chen, MP Dragomir, L Fabris, R Bayraktar, E Knutsen, X Liu, C Tang, ... Gastroenterology 159 (6), 2146-2162. e33, 2020 | 109 | 2020 |
| Ly6E/K signaling to TGF-ß promotes breast cancer progression, immune escape and drug resistance MA Hossiny, L Luo, WR Frazier, N Steiner, Y Gusev, B Kallakury, ... Cancer Research, 2016 | 107 | 2016 |
| Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome L Luo, P McGarvey, S Madhavan, R Kumar, Y Gusev, G Upadhyay Oncotarget, 2016 | 107 | 2016 |
| Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA Y Gusev Methods 44 (1), 61-72, 2008 | 106 | 2008 |
| βII-spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and wnt signaling via regulation of wnt inhibitor kallistatin ARH Xiuling Zhi, Ling Lin, Shaoxian Yang, Krithika Bhuvaneshwar, Hongkun ... Hepatology, 2014 | 103* | 2014 |
| Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer Y Gusev, TD Schmittgen, M Lerner, R Postier, D Brackett BMC bioinformatics 8, 1-17, 2007 | 91 | 2007 |
| Biomarker identification in human pancreatic cancer sera JS Hanas, JR Hocker, JY Cheung, JL Larabee, MR Lerner, SA Lightfoot, ... Pancreas 36 (1), 61-69, 2008 | 84 | 2008 |
| Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice MA Zeiger, M Saji, Y Gusev, WH Westra, Y Takiyama, WC Dooley, ... Endocrinology 138 (8), 3133-3140, 1997 | 84 | 1997 |
| G-DOC: a systems medicine platform for personalized oncology S Madhavan, Y Gusev, M Harris, DM Tanenbaum, R Gauba, ... Neoplasia 13 (9), 771-783, 2011 | 75 | 2011 |
Subha MadhavanGeorgetown Universitygeorgetown.edu의 이메일 확인됨
